March 8, 2025 06:00 AM EST

FDA and NIH nominees sail through Senate hearings; Tariffs’ early impact on drug manufacturing; AbbVie’s move into the obesity market; and more

Welcome back to Endpoints Weekly! This week was another busy one in DC, with two Senate hearings for Trump’s picks to lead the NIH and …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA and NIH nom­i­nees sail through Sen­ate hear­ings; Tar­iffs’ ear­ly im­pact on drug man­u­fac­tur­ing; Ab­b­Vie’s move in­to the obe­si­ty mar­ket; and more